As an investor, Charles Rosier (dooid.me/charlesrosier) gets a profit-share from the company because of his contribution that enabled the company to begin doing the study. He helped Baulieu and his colleagues to develop a new drug by funding the research. He also invested capital in the laboratory of Mapreg, in Paris, to continue performing research about serious conditions including depression and stroke. With his eagerness to contribute to the medical industry, Charles Rosier invested in the Mapreg Drug Project.
His name became big in the industry because he was able to hold different positions throughout his profession. Charles Rosier's first Baccalaureate degree was equivalent to A-levels in the UK. In 1996, he was employed by Lehman Brothers and then became a part of UBS Warburg Investment Bank. Charles Rosier spent two years of extra study in preparation for more French requirements.
The Profession of Charles Rosier
The year 1996 marked Charles Rosier’s first big step towards his future, securing his first appointment at Lehman Brothers. In 1997, he moved to UBS Warburg where he became manager of their Debt Capital Market Division. He is noted as being the most seasoned bankers in over 15 years. Charles Rosier was offered a job at Goldman Sachs in 1999. When he accepted the offer, he became their Managing Director. BTG Pactual has 30 years of experience in international markets and has over 2,500 employees spread across Latin America.
Charles Rosier's Environmental Projects
Charles Rosier is dedicated to helping the environment by developing energy and power sectors in poor countries. MPOWERD was funded by him to develop lanterns and other energy solutions. With this, MPOWERD delivered these solutions to more than 25 poor nations around the planet. Innoveox is a French company dedicated to promoting a pollution-free atmosphere, supported by Charles Rosier.